miR-107 Enhances the Sensitivity of Breast Cancer Cells to Paclitaxel

Breast cancer remains the most commonly diagnosed cancer in Chinese women. Paclitaxel (PTX) is a chemotherapy medication used to treat breast cancer patients. However, a side effect of paclitaxel is the severe drug resistance. Previous studies demonstrated that dysregulation of microRNAs could regul...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Changpo, Shi, Xuejun, Guo, Wenchao, Niu, Jianxin, Wang, Guangshun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555243/
https://www.ncbi.nlm.nih.gov/pubmed/31206033
http://dx.doi.org/10.1515/med-2019-0049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555243/
https://www.ncbi.nlm.nih.gov/pubmed/31206033
http://dx.doi.org/10.1515/med-2019-0049

Ejemplares similares